Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MultiCell to investigate possible bird flu vaccine
These studies, undertaken by the MultiCell Technologies subsidiary, will seek to build on the success that the toll receptor molecule, MCT-465, demonstrated in previous preclinical studies of the
These studies, undertaken by the MultiCell Technologies subsidiary, will seek to build on the success that the toll receptor molecule, MCT-465, demonstrated in previous preclinical studies of the
An aurora kinase inhibitor, CYC116, is a small molecule investigational drug, which has previously demonstrated anticancer activity after oral administration in both hematological and solid tumor models. The
Daily sub-cutaneous or intraperitoneal administration of CTCE-9908 was shown to prevent the spread of cancer to distant organs on average by 61%, providing positive preclinical results for CTCE-9908
Traditional flu-vaccine development involves the process of viral amplification in chicken eggs, followed by a lengthy process of inactivation, sterilization, and packaging. This method is very time consuming
Net income for the third quarter of 2005 was $267 million, an increase of 6% over the third quarter of 2004. Net Sales for the period also increased
The study is an open label, phase I trial evaluating 1D09C3 in patients with relapsed or refractory B-cell tumors who have failed prior standard therapy, and is using
The Serono researchers assessed immune response to influenza vaccine over a four-week period in a total of 163 patients with multiple sclerosis (MS). One group of MS patients
According to an analysis of pooled data from four clinical studies, Nasonex provides effective relief of the nasal congestion often associated with seasonal allergic rhinitis. The results demonstrated
The open label safety study evaluated 397 pediatric asthma patients between the ages of six months and eight years over the course of one and a half years.
The results of a controlled driving simulator study conducted by the Washington Neuropsychological Institute show that Adderall XR, an amphetamine based product, can improve driving ability and safety